• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

4.295 +0.045 (+1.05%)
Streaming Delayed Price Updated: 10:44 AM EST, Jan 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 125,294
Open 4.270
Bid (Size) 4.290 (200)
Ask (Size) 4.300 (500)
Prev. Close 4.250
Today's Range 4.150 - 4.300
52wk Range 1.380 - 7.340
Shares Outstanding 348,875,959
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas
January 12, 2026
From Agenus Inc.
Via Business Wire
News headline image
Agenus (AGEN) Q3 2024 Earnings Call Transcript ↗
January 05, 2026
Agenus (AGEN) Q3 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
+33.0%
+33.0%
1 Month
+15.8%
+15.8%
3 Month
+6.0%
+6.0%
6 Month
-37.1%
-37.1%
1 Year
+36.1%
+36.1%

More News

Read More
News headline image
Agenus (AGEN) Q1 2025 Earnings Call Transcript ↗
January 05, 2026
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For November 10, 2025 ↗
November 10, 2025
Via Benzinga
News headline image
Examining the Future: Agenus's Earnings Outlook ↗
August 08, 2025
Via Benzinga
News headline image
Agenus (AGEN) Q4 2024 Earnings Call Transcript ↗
January 05, 2026
Via The Motley Fool
Topics Earnings
News headline image
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC
December 23, 2025
From Agenus Inc.
Via Business Wire
News headline image
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL
November 19, 2025
From Agenus Inc.
Via Business Wire
News headline image
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
December 12, 2025
From Equity Insider
Via GlobeNewswire
News headline image
Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC
November 18, 2025
From Agenus Inc.
Via Business Wire
News headline image
AGENUS INC (NASDAQ:AGEN) Reports Mixed Q3 2025 Earnings, Driven by One-Time Gain ↗
November 10, 2025
Via Chartmill
News headline image
Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances
November 10, 2025
From Agenus Inc.
Via Business Wire
News headline image
Insights Ahead: Agenus's Quarterly Earnings ↗
November 07, 2025
Via Benzinga
News headline image
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
November 06, 2025
Via MarketMinute
Topics Intellectual Property
News headline image
Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report
November 05, 2025
From Agenus Inc.
Via Business Wire
News headline image
Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025
October 17, 2025
From Agenus Inc.
Via Business Wire
News headline image
Agenus to Host October Stakeholder Briefing Showcasing BOT/BAL Global Momentum and Post-ESMO Insights
October 16, 2025
From Agenus Inc.
Via Business Wire
News headline image
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
September 09, 2025
From Agenus Inc.
Via Business Wire
News headline image
Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 05, 2025
From Agenus, Inc.
Via Business Wire
News headline image
Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight
August 26, 2025
From Agenus Inc.
Via Business Wire
News headline image
Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025
August 19, 2025
From Agenus Inc.
Via Business Wire
News headline image
Monday's pre-market session: top gainers and losers ↗
August 11, 2025
Via Chartmill
News headline image
Agenus Posts 48% Q2 Revenue Miss ↗
August 11, 2025
Via The Motley Fool
News headline image
Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress
August 11, 2025
From Agenus Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 11, 2025 ↗
August 11, 2025
Via Benzinga

Frequently Asked Questions

Is Agenus Inc. - Common Stock publicly traded?
Yes, Agenus Inc. - Common Stock is publicly traded.
What exchange does Agenus Inc. - Common Stock trade on?
Agenus Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Agenus Inc. - Common Stock?
The ticker symbol for Agenus Inc. - Common Stock is AGEN on the Nasdaq Stock Market
What is the current price of Agenus Inc. - Common Stock?
The current price of Agenus Inc. - Common Stock is 4.295
When was Agenus Inc. - Common Stock last traded?
The last trade of Agenus Inc. - Common Stock was at 01/13/26 10:44 AM ET
What is the market capitalization of Agenus Inc. - Common Stock?
The market capitalization of Agenus Inc. - Common Stock is 1.50B
How many shares of Agenus Inc. - Common Stock are outstanding?
Agenus Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap